Exenatide
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4521 publications
SELFormer-guided discovery of xanthohumol and cirsilineol as multi-target natural therapeutics for type 2 diabetes: computational prediction and experimental validation.
Journal: Food & function
Published: April 02, 2026
Correction: Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 31, 2026
Corrigendum to "Exendin-4 alleviates Aβ1-40-induced apoptosis and calcium dysregulation in RPE cells through the CHP1/NHE1 complex" [Biochem. Pharmacol. 247 (2026) 117789].
Journal: Biochemical pharmacology
Published: March 15, 2026
Med14 phosphorylation shapes genomic response to GLP-1 agonists.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 04, 2026
Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis.
Journal: JAMA internal medicine
Published: March 02, 2026
The Effect of GLP-1 Receptor Agonists on Alanine Aminotransferase and Other Metabolic Parameters in Youths with Obesity: A Systematic Review and Meta-Analysis.
Journal: Childhood obesity (Print)
Published: February 20, 2026
Emerging and Established Pharmacotherapies for Smoking Cessation: A Review.
Journal: Cardiology in review
Published: February 16, 2026
The effect of GLP-1 receptor agonists on autophagy: insights gathered from research evaluating neurodegenerative disorders with these agents.
Journal: Acta neuropsychiatrica
Published: February 13, 2026
The Effect of GLP-1 Receptor Agonists on Autophagy: Insights Gathered from Research Evaluating Neurodegenerative Disorders With These Agents.
Journal: Acta neuropsychiatrica
Published: February 13, 2026
Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: February 12, 2026
A Pharmacovigilance Analysis of Ocular Adverse Events Associated with GLP-1 Receptor Agonists.
Journal: Journal of clinical medicine
Published: February 04, 2026
Glucagon-like peptide-1 receptor agonists in individuals with severe mental illness: A systematic review and meta-analysis of randomized controlled trials.
Journal: International journal of psychiatry in medicine
Published: January 31, 2026
Last Updated: 04/28/2026